Thank you very much for posting this research, Phosphene. Seeing behind the curtain reaffirms that Mymetics is indeed still at the forefront of vaccine research. Numerous patents, novel delivery systems, and ongoing studies across major clinical disorders affirm the significant contributions of this small company to the biotech sector. We wait and hope while negotiations continue toward a sale or collaboration that advances the opportunities and rewards the achievements of MYMX.
News 
Market Data 
Discover 
AI
